It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We address the problem of generating novel molecules with desired interaction properties as a multi-objective optimization problem. Interaction binding models are learned from binding data using graph convolution networks (GCNs). Since the experimentally obtained property scores are recognised as having potentially gross errors, we adopted a robust loss for the model. Combinations of these terms, including drug likeness and synthetic accessibility, are then optimized using reinforcement learning based on a graph convolution policy approach. Some of the molecules generated, while legitimate chemically, can have excellent drug-likeness scores but appear unusual. We provide an example based on the binding potency of small molecules to dopamine transporters. We extend our method successfully to use a multi-objective reward function, in this case for generating novel molecules that bind with dopamine transporters but not with those for norepinephrine. Our method should be generally applicable to the generation in silico of molecules with desirable properties.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Department of Biochemistry and Systems Biology, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470); Indian Institute of Technology Bombay, Mumbai, India (GRID:grid.417971.d) (ISNI:0000 0001 2198 7527)
2 Dept of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
3 Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Department of Biochemistry and Systems Biology, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470)
4 Dept of Computer Science, University of Liverpool, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470)
5 Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Department of Biochemistry and Systems Biology, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470); The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)